Product News

Share this article:
The FDA has granted Caraco Pharmaceutical Laboratories approval for its Abbreviated New Drug Application (ANDA) for Phentermine Hydrochloride Tablets indicated as short-term monotherapy for the management of exogenous obesity. According to IMS data, for the 12 months ended June 2007, Phentermine HCl generic and brand products (Adipex-P) combined had annual sales of approximately $34 million.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Novartis apologizes for slow reporting

Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

Pfizer buys two Baxter vaccines

The meningitis and encephalitis medications earned a combined $300 million last year.